The immune system is able to distinguish self from non-self and dangerous from harmless. Allergic diseases represent the most notable failure in this system. The understanding, the research, diagnosis and management of allergies are therefore always related to immunology. Biologicals are becoming available that can selectively correct overshooting immune reactions. At the same time the costs of treatments increase and personalized approaches along with a sophisticated biomarker diagnosis are required to focus expenses to those patients who are most likely to benefit from it.
The progress of immunology and allergy is greatly enhanced by novel technologies (omics) and our understanding of the diseases has become too complex to be surveyed by individuals.
From these developments the immunology section is going to extend its activities and aims
- to promote understanding of the etiology of allergic diseases and of mechanisms of basic and clinical immunology
- to foster the communication between basic immunology and clinical allergy
- to encourage training in basic immunology for young investigators /physician-scientists
- to promote the understanding and use of biologicals
- to promote approaches in personalized medicine and bio/immunomarkers
- to promote education and research collaboration in immune-“omic” applications.
EAACI Immunology Section Board 2015-2017 during EAACI Annual Meeting Vienna 2016